Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease

This study describes issues related to the safety and tolerability of fetal striatal neural allografts as assessed in five patients with Huntington's disease. Huntington's disease (HD) is characterized by motor, cognitive, and behavioral disturbances. The latter include psychological disturbances and, as a consequence, we took particular care to analyze behavioral changes, in addition to the usual "safety" follow-up. We conducted multidisciplinary follow-up at least 2 years before and 1 year after grafting. Psychological care extended to close relatives. The grafting procedure itself was altogether safe and uneventful, and there were no apparent clinical deleterious effects for 1 year. The immunosuppressive treatment, however, was complicated by various problems (irregular compliance, errors of handling, side effects). Direct psychological consequences of the transplantation procedure were rare and not worrisome, although mood alteration requiring treatment was observed in one patient. Indirectly, however, the procedure required patients and relatives to accept constraints that tended to complicate familial situations already marred by aggressivity and depression. All patients and close relatives expressed major expectations, in spite of our strong and repeated cautioning. It is clearly important to be aware of these particular conditions since they may eventually translate into psychological difficulties in coping with the long-term clinical outcome of the procedure, if not beneficial. Despite an overall good tolerance, therefore, this follow-up calls for caution regarding the involvement of HD patients in experimental surgical protocols.

[1]  Françoise Condé,et al.  Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease , 1998, Nature Medicine.

[2]  R. Ridley,et al.  Functional integration of striatal allografts in a primate model of Huntington's disease , 1998, Nature Medicine.

[3]  P. Remy,et al.  MRI-Stereotactical Approach for Neural Grafting in Basal Ganglia Disorders , 1998, Experimental Neurology.

[4]  S. Jacques,et al.  Safety of Intrastriatal Neurotransplantation for Huntington's Disease Patients , 1998, Experimental Neurology.

[5]  Björn Gustavii,et al.  Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease , 1997, Annals of neurology.

[6]  D. Riche,et al.  Maturation of Fetal Human Neural Xenografts in the Adult Rat Brain , 1997, Experimental Neurology.

[7]  O. Lindvall,et al.  Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT‐HD) , 1996, Movement disorders : official journal of the Movement Disorder Society.

[8]  Y. Samson,et al.  Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. , 1996, Brain : a journal of neurology.

[9]  D. Riche,et al.  Ontogeny of Human Striatal DARPP-32 Neurons in Fetuses and Following Xenografting to the Adult Rat Brain , 1996, Experimental Neurology.

[10]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[11]  M. Peschanski,et al.  Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease , 1995, Neuroscience.

[12]  F. Vingerhoets,et al.  Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease , 1995, Annals of neurology.

[13]  C. Verney,et al.  Development of the catecholamine neurons in human embryos and fetuses, with special emphasis on the innervaton of the cerebral cortex , 1995, The Journal of comparative neurology.

[14]  J. Cummings,et al.  Behavioral and psychiatric symptoms associated with Huntington's disease. , 1995, Advances in neurology.

[15]  S. Juliano,et al.  Long-term delayed vascularization of human neural transplants to the rat brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  Y. Samson,et al.  Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. , 1994, Brain : a journal of neurology.

[17]  G. Campanella,et al.  Suicide risk in Huntington's disease. , 1993, Journal of medical genetics.

[18]  M. Peschanski,et al.  Apport de l'échographie dans les prélèvements embryonnaires à visée de greffes intracérébrales dans le traitement de la maladie de Parkinson , 1993 .

[19]  K. Fenger,et al.  Causes of death in patients with Huntington's disease and in unaffected first degree relatives. , 1992, Journal of medical genetics.

[20]  Scott T. Grafton,et al.  Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. , 1992, The New England journal of medicine.

[21]  D. Spencer,et al.  Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. , 1992, The New England journal of medicine.

[22]  B. Berger,et al.  Early evidence of catecholaminergic cell groups in 5- and 6-week-old human embryos using tyrosine hydroxylase and dopamine-β-hydroxylase immunocytochemistry , 1991, Neuroscience Letters.

[23]  J. Mugler,et al.  Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE) , 1990, Magnetic resonance in medicine.

[24]  C D Marsden,et al.  Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. , 1990, Science.

[25]  M. Folstein,et al.  Clinical Assessment of Irritability, Aggression, and Apathy in Huntington and Alzheimer Disease , 1990, The Journal of nervous and mental disease.

[26]  Ira Shoulson,et al.  Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individuals , 1990, Movement disorders : official journal of the Movement Disorder Society.

[27]  J. Keeling Development of the Human Fetal Brain. An Anatomical Atlas , 1989 .

[28]  S. Folstein,et al.  The diagnosis of Huntington's disease , 1986, Neurology.

[29]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[30]  E. Mancall,et al.  Development of neuropsychological deficits in Huntington's disease. , 1983, Archives of neurology.

[31]  I. Shoulson,et al.  Psychiatric syndromes in Huntington's disease. , 1983, The American journal of psychiatry.

[32]  I. Shoulson,et al.  Dementia in Huntington disease: a cross-sectional analysis of intellectual decline. , 1983, Advances in neurology.

[33]  C. Golden,et al.  Neuropsychological deficits in early, middle, and late stage Huntington's disease as measured by the Luria-Nebraska Neuropsychological Battery. , 1981, The International journal of neuroscience.

[34]  C. J. Brackenridge Relation of occupational stress to the age at onset of Huntington's disease , 1979, Acta neurologica Scandinavica.

[35]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[36]  N. Butters,et al.  Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. , 1978, Archives of neurology.

[37]  J. Bolt Huntington's Chorea in the West of Scotland , 1970, British Journal of Psychiatry.

[38]  E. M. Hughes SOCIAL SIGNIFICANCE OF HUNTINGTON'S CHOREA , 1925 .